United States Pharmaceuticals

EyePoint Inc (EYPT)

Track

Track

EyePoint Inc. experienced significant insider trading activity recently, characterized by substantial divestments alongside a singular purchase. Following a disappointing earnings report, the stock price declined sharply. While executives offloaded shares, one individual acquired equity, reflecting mixed sentiment amidst ongoing market volatility and a challenging performance trajectory for the healthcare firm.
Ticker: EYPT Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for EyePoint Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.7
Zaderej Karen L. Non-Executive Director
Transaction date
Purchase
Price
95.53
Quantity 87,274 +24.7%
Value US$133,085
3.4
Lurker Nancy Director Non-Executive Director
Transaction date
Proposed sale
Price
52.27
Quantity 19,548
Value US$885,324
3.4
Lurker Nancy Officer Officer
Transaction date
Proposed sale
Price
148.54
Quantity 77,614
Value US$2,741,747
3.4
Lurker Nancy Officer Officer
Transaction date
Proposed sale
Price
13.05
Quantity 421,235
Value US$5,497,117
4.1
Ribeiro Ramiro Chief Medical Officer Officer
Transaction date
Sale
Price
15.02
Quantity 2,438 -100.0%
Value US$36,612
4.1
Ribeiro Ramiro Chief Medical Officer Officer
Transaction date
Sale
Price
15.00
Quantity 2,437 -50.0%
Value US$36,555
4.1
Ribeiro Ramiro Chief Medical Officer Officer
Transaction date
Sale
Price
15.00
Quantity 2,437 -100.0%
Value US$36,555
4.1
Ramiro Ribeiro Officer Officer
Transaction date
Proposed sale
Price
14.81
Quantity 9,750
Value US$144,398
2.3
Duker Jay S. President and CEO Executive Director
Transaction date
Purchase
Price
13.15
Quantity 1,500 +1.5%
Value US$19,724
4.1
Ribeiro Ramiro Chief Medical Officer Officer
Transaction date
Sale
Price
17.87
Quantity 2,438 -100.0%
Value US$43,572
4.1
Ribeiro Ramiro Chief Medical Officer Officer
Transaction date
Sale
Price
15.00
Quantity 2,437 -100.0%
Value US$36,555
4.1
Ribeiro Ramiro Chief Medical Officer Officer
Transaction date
Sale
Price
17.10
Quantity 42,544 -100.0%
Value US$727,319
4.1
Ramiro Ribeiro Officer Officer
Transaction date
Proposed sale
Price
17.48
Quantity 53,792
Value US$940,284
3.4
Lurker Nancy Non-Executive Director
Transaction date
Sale
Price
15.11
Quantity 9,300 -4.3%
Value US$140,477
3.4
Lurker Nancy Officer Officer
Transaction date
Proposed sale
Price
15.11
Quantity 9,300
Value US$140,477
3.4
Lurker Nancy Non-Executive Director
Transaction date
Sale
Price
14.95
Quantity 500 -0.2%
Value US$7,475
3.4
Lurker Nancy Officer Officer
Transaction date
Proposed sale
Price
14.95
Quantity 500
Value US$7,475
3.4
Lurker Nancy Non-Executive Director
Transaction date
Sale
Price
14.95
Quantity 200 -0.1%
Value US$2,990
3.4
Lurker Nancy Officer Officer
Transaction date
Proposed sale
Price
14.95
Quantity 200
Value US$2,990
4.1
Ramiro Ribeiro Officer Officer
Transaction date
Proposed sale
Price
11.35
Quantity 2,722
Value US$30,895
4.1
Ribeiro Ramiro Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.61
Quantity 2,722 -100.0%
Value US$31,602
3.7
Zaderej Karen L. Non-Executive Director
Transaction date
Purchase
Price
5.99
Quantity 5,000 +15.9%
Value US$29,950
3.7
Zaderej Karen L. Non-Executive Director
Transaction date
Purchase
Price
5.81
Quantity 5,000 +18.9%
Value US$29,050
3.7
Zaderej Karen L. Non-Executive Director
Transaction date
Purchase
Price
5.47
Quantity 5,000 +23.3%
Value US$27,350
3.7
Zaderej Karen L. Non-Executive Director
Transaction date
Purchase
Price
5.42
Quantity 5,000 +30.3%
Value US$27,100
ANTHONY P. ADAMIS Director Non-Executive Director
Transaction date
Proposed sale
Price
10.04
Quantity 67,100
Value US$673,355
3.7
David R. Guyer Former Director Non-Executive Director
Transaction date
Proposed sale
Price
8.92
Quantity 36,975
Value US$329,817
3.7
ANDO GORAN Non-Executive Director
Transaction date
Purchase
Price
7.95
Quantity 5,000 +61.3%
Value US$39,750
2.4
DICICCO WENDY F Non-Executive Director
Transaction date
Purchase
Price
7.79
Quantity 2,567 +34.7%
Value US$19,997
3.7
Zaderej Karen L. Non-Executive Director
Transaction date
Purchase
Price
7.98
Quantity 12,500 +312.5%
Value US$99,750
3.4
Lurker Nancy Non-Executive Director
Transaction date
Purchase
Price
7.88
Quantity 3,173 +3.4%
Value US$25,003
3.7
GUYER DAVID R Non-Executive Director
Transaction date
Sale
Price
10.06
Quantity 11,625 -86.3%
Value US$116,995
3.7
GUYER DAVID R Non-Executive Director
Transaction date
Sale
Price
10.30
Quantity 11,625 -75.9%
Value US$119,705
3.7
GUYER DAVID R Non-Executive Director
Transaction date
Sale
Price
12.65
Quantity 11,625 -67.7%
Value US$147,045
3.7
David R. Guyer Director Non-Executive Director
Transaction date
Proposed sale
Price
12.49
Quantity 71,850
Value US$897,407
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
28.49
Quantity 209 -0.5%
Value US$5,954
2.8
DAVID S JONES Officer Officer
Transaction date
Proposed sale
Price
28.51
Quantity 10,104
Value US$288,065
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
25.77
Quantity 33,665 -48.0%
Value US$867,672
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
25.41
Quantity 15,609 -18.2%
Value US$396,572
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
25.41
Quantity 51 -0.1%
Value US$1,296
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
25.27
Quantity 9,604 -20.2%
Value US$242,717
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
25.45
Quantity 16,413 -25.7%
Value US$417,653
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
25.00
Quantity 300 -0.8%
Value US$7,500
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
25.00
Quantity 300 -0.8%
Value US$7,500
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
25.00
Quantity 300 -0.8%
Value US$7,500
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
25.00
Quantity 300 -0.8%
Value US$7,500
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
25.01
Quantity 5,600 -12.9%
Value US$140,068
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
25.01
Quantity 5,700 -11.6%
Value US$142,554
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
25.02
Quantity 5,651 -13.4%
Value US$141,363
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
25.01
Quantity 5,600 -11.7%
Value US$140,052
3.4
Lurker Nancy Executive Vice Chair Executive Director
Transaction date
Sale
Price
24.98
Quantity 29,956 -18.1%
Value US$748,250
3.4
Lurker Nancy Director Non-Executive Director
Transaction date
Proposed sale
Price
24.98
Quantity 29,956
Value US$748,250
2.8
DAVID S JONES Officer Officer
Transaction date
Proposed sale
Price
24.91
Quantity 34,442
Value US$857,950
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
25.00
Quantity 3,096 -7.8%
Value US$77,400
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
25.00
Quantity 2,039 -4.9%
Value US$50,975
3.4
Lurker Nancy Executive Vice Chair Executive Director
Transaction date
Sale
Price
24.97
Quantity 5,044 -3.0%
Value US$125,950
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
25.00
Quantity 500 -1.3%
Value US$12,500
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
25.00
Quantity 400 -1.0%
Value US$10,000
3.4
Lurker Nancy Director Non-Executive Director
Transaction date
Proposed sale
Price
24.97
Quantity 5,044
Value US$125,950
2.9
DARIO A PAGGIARINO Officer Officer
Transaction date
Proposed sale
Price
23.98
Quantity 66,311
Value US$1,590,138
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
22.69
Quantity 28,750 -43.1%
Value US$652,254
2.8
Jones David Scott SVP & Chief Commercial Officer Officer
Transaction date
Sale
Price
22.24
Quantity 5,416 -7.5%
Value US$120,437
2.8
DAVID S JONES Officer Officer
Transaction date
Proposed sale
Price
22.32
Quantity 38,541
Value US$860,235
2.0
Liu Ye Non-Executive Director
Transaction date
Sale
Price
19.45
Quantity 1,910,500 -95.0%
Value US$37,159,225
1.7
Ocumension Therapeutics Non-Executive Director
Transaction date
Sale
Price
19.45
Quantity 1,910,500 -95.0%
Value US$37,159,225
1.7
Ocumension Therapeutics Director Non-Executive Director
Transaction date
Proposed sale
Price
19.45
Quantity 1,910,500
Value US$37,159,225
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
21.13
Quantity 22,913 -38.6%
Value US$484,124
2.9
Paggiarino Dario A. Chief Medical Officer Officer
Transaction date
Sale
Price
20.00
Quantity 1,458 -5.4%
Value US$29,160
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-18 B Purchase
3.7
Zaderej Karen L.
Non-Executive Director
87,274 +24.7%
95.53
US$133,085 		87,274 +24.7% 95.53 US$133,085
2026-07-22 2026-07-22 PrS Proposed sale
3.4
Lurker Nancy

Director

Non-Executive Director
19,548
52.27
US$885,324 		19,548 52.27 US$885,324
2026-07-22 2026-07-22 PrS Proposed sale
3.4
Lurker Nancy

Officer

Officer
77,614
148.54
US$2,741,747 		77,614 148.54 US$2,741,747
2026-07-21 2026-07-21 PrS Proposed sale
3.4
Lurker Nancy

Officer

Officer
421,235
13.05
US$5,497,117 		421,235 13.05 US$5,497,117
2026-07-02 2026-06-30 S Sale
4.1
Ribeiro Ramiro

Chief Medical Officer

Officer
2,438 -100.0%
15.02
US$36,612 		2,438 -100.0% 15.02 US$36,612
2026-07-02 2026-06-30 S Sale
4.1
Ribeiro Ramiro

Chief Medical Officer

Officer
2,437 -50.0%
15.00
US$36,555 		2,437 -50.0% 15.00 US$36,555
2026-04-20 2026-04-17 S Sale
4.1
Ribeiro Ramiro

Chief Medical Officer

Officer
2,437 -100.0%
15.00
US$36,555 		2,437 -100.0% 15.00 US$36,555
2026-04-17 2026-04-17 PrS Proposed sale
4.1
Ramiro Ribeiro

Officer

Officer
9,750
14.81
US$144,398 		9,750 14.81 US$144,398
2026-03-16 2026-03-16 B Purchase
2.3
Duker Jay S.

President and CEO

Executive Director
1,500 +1.5%
13.15
US$19,724 		1,500 +1.5% 13.15 US$19,724
2026-03-05 2026-03-04 S Sale
4.1
Ribeiro Ramiro

Chief Medical Officer

Officer
2,438 -100.0%
17.87
US$43,572 		2,438 -100.0% 17.87 US$43,572
2026-02-18 2026-02-17 S Sale
4.1
Ribeiro Ramiro

Chief Medical Officer

Officer
2,437 -100.0%
15.00
US$36,555 		2,437 -100.0% 15.00 US$36,555
2026-01-07 2026-01-05 S Sale
4.1
Ribeiro Ramiro

Chief Medical Officer

Officer
42,544 -100.0%
17.10
US$727,319 		42,544 -100.0% 17.10 US$727,319
2026-01-05 2026-01-05 PrS Proposed sale
4.1
Ramiro Ribeiro

Officer

Officer
53,792
17.48
US$940,284 		53,792 17.48 US$940,284
2025-12-08 2025-12-04 S Sale
3.7
Cormorant Asset Management, LP

Former 10% Owner
60,000 -0.7%
15.70
US$942,240 		60,000 -0.7% 15.70 US$942,240
2025-12-05 2025-12-04 S Sale
3.4
Lurker Nancy
Non-Executive Director
9,300 -4.3%
15.11
US$140,477 		9,300 -4.3% 15.11 US$140,477
2025-12-04 2025-12-04 PrS Proposed sale
3.4
Lurker Nancy

Officer

Officer
9,300
15.11
US$140,477 		9,300 15.11 US$140,477
2025-12-01 2025-11-28 S Sale
3.4
Lurker Nancy
Non-Executive Director
500 -0.2%
14.95
US$7,475 		500 -0.2% 14.95 US$7,475
2025-11-28 2025-11-28 PrS Proposed sale
3.4
Lurker Nancy

Officer

Officer
500
14.95
US$7,475 		500 14.95 US$7,475
2025-12-01 2025-11-26 S Sale
3.4
Lurker Nancy
Non-Executive Director
200 -0.1%
14.95
US$2,990 		200 -0.1% 14.95 US$2,990
2025-11-26 2025-11-26 PrS Proposed sale
3.4
Lurker Nancy

Officer

Officer
200
14.95
US$2,990 		200 14.95 US$2,990
2025-11-12 2025-11-11 PrS Proposed sale
4.1
Ramiro Ribeiro

Officer

Officer
2,722
11.35
US$30,895 		2,722 11.35 US$30,895
2025-11-12 2025-11-11 PlS Planned sale
4.1
Ribeiro Ramiro

Chief Medical Officer

Officer
2,722 -100.0%
11.61
US$31,602 		2,722 -100.0% 11.61 US$31,602
2025-05-19 2025-05-19 B Purchase
3.7
Zaderej Karen L.
Non-Executive Director
5,000 +15.9%
5.99
US$29,950 		5,000 +15.9% 5.99 US$29,950
2025-05-19 2025-05-16 B Purchase
3.7
Zaderej Karen L.
Non-Executive Director
5,000 +18.9%
5.81
US$29,050 		5,000 +18.9% 5.81 US$29,050
2025-05-15 2025-05-15 B Purchase
3.7
Zaderej Karen L.
Non-Executive Director
5,000 +23.3%
5.47
US$27,350 		5,000 +23.3% 5.47 US$27,350
2025-05-15 2025-05-14 B Purchase
3.7
Zaderej Karen L.
Non-Executive Director
5,000 +30.3%
5.42
US$27,100 		5,000 +30.3% 5.42 US$27,100
2024-10-23 2024-10-23 PrS Proposed sale
ANTHONY P. ADAMIS

Director

Non-Executive Director
67,100
10.04
US$673,355 		67,100 10.04 US$673,355
2024-10-15 2024-10-14 PrS Proposed sale
3.7
David R. Guyer

Former Director

Non-Executive Director
36,975
8.92
US$329,817 		36,975 8.92 US$329,817
2024-08-21 2024-08-21 B Purchase
3.7
ANDO GORAN
Non-Executive Director
5,000 +61.3%
7.95
US$39,750 		5,000 +61.3% 7.95 US$39,750
2024-08-21 2024-08-20 B Purchase
2.4
DICICCO WENDY F
Non-Executive Director
2,567 +34.7%
7.79
US$19,997 		2,567 +34.7% 7.79 US$19,997
2024-08-21 2024-08-19 B Purchase
3.7
Zaderej Karen L.
Non-Executive Director
12,500 +312.5%
7.98
US$99,750 		12,500 +312.5% 7.98 US$99,750
2024-08-20 2024-08-16 B Purchase
3.4
Lurker Nancy
Non-Executive Director
3,173 +3.4%
7.88
US$25,003 		3,173 +3.4% 7.88 US$25,003
2024-07-16 2024-07-12 S Sale
3.7
GUYER DAVID R
Non-Executive Director
11,625 -86.3%
10.06
US$116,995 		11,625 -86.3% 10.06 US$116,995
2024-06-04 2024-06-03 S Sale
3.7
GUYER DAVID R
Non-Executive Director
11,625 -75.9%
10.30
US$119,705 		11,625 -75.9% 10.30 US$119,705
2024-05-16 2024-05-14 S Sale
3.7
GUYER DAVID R
Non-Executive Director
11,625 -67.7%
12.65
US$147,045 		11,625 -67.7% 12.65 US$147,045
2024-05-14 2024-05-14 PrS Proposed sale
3.7
David R. Guyer

Director

Non-Executive Director
71,850
12.49
US$897,407 		71,850 12.49 US$897,407
2024-05-08 2024-05-06 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
207,153 +2.6%
12.36
US$2,560,411 		207,153 +2.6% 12.36 US$2,560,411
2024-05-08 2024-05-06 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
642,847 +8.6%
11.70
US$7,521,310 		642,847 +8.6% 11.70 US$7,521,310
2024-04-22 2024-04-18 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
186,521 +2.6%
18.90
US$3,525,247 		186,521 +2.6% 18.90 US$3,525,247
2024-04-22 2024-04-18 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
395,244 +5.7%
17.62
US$6,964,199 		395,244 +5.7% 17.62 US$6,964,199
2024-02-05 2024-02-02 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
209 -0.5%
28.49
US$5,954 		209 -0.5% 28.49 US$5,954
2024-02-02 2024-02-02 PrS Proposed sale
2.8
DAVID S JONES

Officer

Officer
10,104
28.51
US$288,065 		10,104 28.51 US$288,065
2024-01-30 2024-01-26 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
33,665 -48.0%
25.77
US$867,672 		33,665 -48.0% 25.77 US$867,672
2024-01-30 2024-01-26 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
15,609 -18.2%
25.41
US$396,572 		15,609 -18.2% 25.41 US$396,572
2024-01-30 2024-01-26 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
51 -0.1%
25.41
US$1,296 		51 -0.1% 25.41 US$1,296
2024-01-29 2024-01-26 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
9,604 -20.2%
25.27
US$242,717 		9,604 -20.2% 25.27 US$242,717
2024-01-29 2024-01-26 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
16,413 -25.7%
25.45
US$417,653 		16,413 -25.7% 25.45 US$417,653
2024-01-29 2024-01-25 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
300 -0.8%
25.00
US$7,500 		300 -0.8% 25.00 US$7,500
2024-01-29 2024-01-25 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
300 -0.8%
25.00
US$7,500 		300 -0.8% 25.00 US$7,500
2024-01-26 2024-01-25 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
300 -0.8%
25.00
US$7,500 		300 -0.8% 25.00 US$7,500
2024-01-26 2024-01-25 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
300 -0.8%
25.00
US$7,500 		300 -0.8% 25.00 US$7,500
2024-01-26 2024-01-24 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
5,600 -12.9%
25.01
US$140,068 		5,600 -12.9% 25.01 US$140,068
2024-01-26 2024-01-24 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
5,700 -11.6%
25.01
US$142,554 		5,700 -11.6% 25.01 US$142,554
2024-01-25 2024-01-24 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
5,651 -13.4%
25.02
US$141,363 		5,651 -13.4% 25.02 US$141,363
2024-01-25 2024-01-24 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
5,600 -11.7%
25.01
US$140,052 		5,600 -11.7% 25.01 US$140,052
2024-01-25 2024-01-24 S Sale
3.4
Lurker Nancy

Executive Vice Chair

Executive Director
29,956 -18.1%
24.98
US$748,250 		29,956 -18.1% 24.98 US$748,250
2024-01-24 2024-01-24 PrS Proposed sale
3.4
Lurker Nancy

Director

Non-Executive Director
29,956
24.98
US$748,250 		29,956 24.98 US$748,250
2024-01-24 2024-01-24 PrS Proposed sale
2.8
DAVID S JONES

Officer

Officer
34,442
24.91
US$857,950 		34,442 24.91 US$857,950
2024-01-25 2024-01-23 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
3,096 -7.8%
25.00
US$77,400 		3,096 -7.8% 25.00 US$77,400
2024-01-25 2024-01-23 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
2,039 -4.9%
25.00
US$50,975 		2,039 -4.9% 25.00 US$50,975
2024-01-25 2024-01-23 S Sale
3.4
Lurker Nancy

Executive Vice Chair

Executive Director
5,044 -3.0%
24.97
US$125,950 		5,044 -3.0% 24.97 US$125,950
2024-01-24 2024-01-23 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
500 -1.3%
25.00
US$12,500 		500 -1.3% 25.00 US$12,500
2024-01-24 2024-01-23 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
400 -1.0%
25.00
US$10,000 		400 -1.0% 25.00 US$10,000
2024-01-23 2024-01-23 PrS Proposed sale
3.4
Lurker Nancy

Director

Non-Executive Director
5,044
24.97
US$125,950 		5,044 24.97 US$125,950
2024-01-23 2024-01-23 PrS Proposed sale
2.9
DARIO A PAGGIARINO

Officer

Officer
66,311
23.98
US$1,590,138 		66,311 23.98 US$1,590,138
2024-01-24 2024-01-22 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
28,750 -43.1%
22.69
US$652,254 		28,750 -43.1% 22.69 US$652,254
2024-01-24 2024-01-22 S Sale
2.8
Jones David Scott

SVP & Chief Commercial Officer

Officer
5,416 -7.5%
22.24
US$120,437 		5,416 -7.5% 22.24 US$120,437
2024-01-22 2024-01-22 PrS Proposed sale
2.8
DAVID S JONES

Officer

Officer
38,541
22.32
US$860,235 		38,541 22.32 US$860,235
2024-01-16 2024-01-11 S Sale
2.0
Liu Ye
Non-Executive Director
1,910,500 -95.0%
19.45
US$37,159,225 		1,910,500 -95.0% 19.45 US$37,159,225
2024-01-16 2024-01-11 S Sale
1.7
Ocumension Therapeutics
Non-Executive Director
1,910,500 -95.0%
19.45
US$37,159,225 		1,910,500 -95.0% 19.45 US$37,159,225
2024-01-11 2024-01-11 PrS Proposed sale
1.7
Ocumension Therapeutics

Director

Non-Executive Director
1,910,500
19.45
US$37,159,225 		1,910,500 19.45 US$37,159,225
2024-01-11 2024-01-11 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
750,000 +12.2%
19.75
US$14,812,500 		750,000 +12.2% 19.75 US$14,812,500
2024-01-11 2024-01-09 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
105,000 +1.7%
21.32
US$2,238,600 		105,000 +1.7% 21.32 US$2,238,600
2024-01-10 2024-01-08 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
22,913 -38.6%
21.13
US$484,124 		22,913 -38.6% 21.13 US$484,124
2023-12-15 2023-12-13 S Sale
2.9
Paggiarino Dario A.

Chief Medical Officer

Officer
1,458 -5.4%
20.00
US$29,160 		1,458 -5.4% 20.00 US$29,160
Explore more

More insider trading research around EyePoint Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America